Recent discoveries on immune checkpoint inhibitors, such as programmed cell death ligand‐1 (PD‐L1) and programmed cell death‐1 (PD‐1), have led to improved survival rates for various forms of cancer [37]. This evidence concerns the gene CD274 and cancer.